University of Oxford named best UK university for producing successful spinouts
The IP experts at GovGrant have revealed the high achieving UK universities that have generated the most spinout companies in the last two decades, including spin-out company valuation, according to the University Spinout Report 2021.
A new report has named the University of Oxford as the most prolific at commercialising innovation in the UK, according to research into university spinout companies. Spinouts have raised a total of £3.1 billion through the university, whilst also generating some of the highest value spinout companies in the UK, with the most successful being Oxford Nanopore Technologies, currently valued at £2.39 billion.
The University Spinout Report 2021 was produced by IP specialists and R&D tax credit experts GovGrant to celebrate the UK’s position as a global leader in innovation. It is based on analysis of just under 1,000 UK spinout companies, a sample that comprises £19.28 billion of capital invested, 4,489 deals and 1,907 investors.
One sixth of spinout companies in the UK (16%) originated from Oxford University. This is followed by the University of Cambridge with more than 11% of UK spinout companies and Imperial College London, which has contributed to 9% of the UK total.
Analysing company data, the University of Oxford has six spinouts in the top 10 by value, with a total value of £8.1 billion. Imperial College London’s leading spinout is Ceres Power, which comes second in the top 10 and is valued at £1.98 billion.
In total, the top 10 UK spinout companies by valuation are worth approximately £9.8 billion. Of these 10, eight are in the healthcare industry. Healthcare is the dominant sector for successful UK spinouts, accounting for 45%. IT is the next most successful with 24%, almost half as many as healthcare.
“This report highlights the huge value to the economy of UK universities, as well as the incredible depth of creativity and talent at our universities.”
“It’s no surprise to see pharmaceutical and biotech spinouts feature prominently: the UK is particularly renowned for innovation in these areas. You only need to look at the recent development of Covid-19 vaccines in the UK to see how accomplished we are in pharmaceutical innovation.”
Adam Simmonds, Investment Research Analyst at GovGrant